Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT06697730
Active, not recruiting Observational

Study of the Incidence and Prognosis of Intrahospital Acute Kidney Injury

NCT06697730 · tracked via the Priya Life Science Italy tracker
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Phase
Observational
Started
2025-11-25
Last updated
2026-03-27

Condition(s) studied

Acute Kidney Injury

Study summary

The goal of this observational study is to investigate the epidemiology of acute kidney injury in hospitalized patients. The main question it aims to answer is: how frequent is the development of acute kidney injury in patients who are hospitalized? Data from participants will be retrospectively collected from medical charts.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients hospitalised from 01/01/2019 to 31/12/2023 * Availability of a Hospital Discharge Form * At least one serum creatinine (sCr) determination available Exclusion Criteria: * Day-hospital admission * Discharge after an emergency room admission without hospital admission * Stage IV and V CKD

Primary outcome measure(s)

  • Incidence of intra-hospital Acute Kidney Injury — From 01/01/2019 to 12/31/2023

Trial sites (1)

FacilityCityRegionStatus
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

More Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico trials in Italy

Risk Factors, Incidence, and Clinical Impact of Intraluminal Thrombosis Following FET and TEVAR Starting soon
Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's Disease. Open-label, Single-center Randomized Study Recruiting
Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis Recruiting
DEFINITION OF THE GENOMIC LANDSCAPE OF MASLD Recruiting
Genetic Diagnosis and Personalized Medicine for Patients With Epilepsy Recruiting

Other trials for the same condition

Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients Recruiting
Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery Recruiting
Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy Recruiting
Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure Recruiting
PREdiction of succeSSful weanING From Continuous Renal Replacement Theraphy: the Possible Role of Delta C-cistatin Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06697730 on ClinicalTrials.gov ↗ ← All trials in Italy